Recruiting OBSERVATIONAL NCT06833229
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma (FDG Immun Comb)
Sponsor: Centre Antoine Lacassagne
Conditions
Carcinoma, Non-Small-Cell Lung (NSCLC)
Interventions
FDG-PET
Updated 2 times since 2025 Last updated: Apr 9, 2025 Started: Jan 27, 2022 Primary completion: May 27, 2028 Completion: Jan 27, 2031
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Carcinoma, Non-Small-Cell Lung (NSCLC) and is currently actively recruiting participants. Centre Antoine Lacassagne leads this study, which shows 2 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
2 versions recorded-
May 2025 — Present [monthly]
Recruiting
-
Mar 2025 — May 2025 [monthly]
Recruiting
First recorded
Jan 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Centre Antoine Lacassagne
Data source: Centre Antoine Lacassagne
For direct contact, visit the study record on ClinicalTrials.gov .